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Summary Bungarus caeruleus (Indian common krait) bite during monsoons is com-
mon in Northwest India. This study was undertaken to ﬁnd the effectiveness of
neostigmine and polyvalent antivenom in improving neuromuscular paralysis follow-
ing bite. All the consecutive patients admitted between June 2007 and December
2008 with common krait bite, identiﬁed either from brought snake or circumstan-
tial evidence were studied. Ten vials of polyvalent antivenom and three doses of
2.5mg neostigmine at 30min intervals after administration of 0.6mg of atropine
were administered I.V. and patients were assessed for any improvement in neu-
roparalysis. Seventy-two patients were admitted during the study period. All the
patients except two came from rural areas and were brought between June and
September. Sixty-two patients were bitten during the day while clearing bricks, cut-
ting grass or walking. The mean time interval between bite and arrival to hospital
was 4.5 h. None of the patients showed any improvement following treatment and
all patients developed respiratory paralysis, requiring assisted ventilation. Seventy
survived and two died. Neostigmine is ineffective in reversing or improving neuropar-
alytic features in patients with B. caeruleus bite even at higher dose than normally
recommended.
© 2010 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
Ltd. All rights reserved.
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Introduction
The common krait (Bungarus caeruleus) is the
most toxic snake found commonly in the plains
of Northwest India and bites typically occur dur-
ing July—September [1—3]. Kraits are elapid snakes
and within the single genus Bungarus, 12 species
are found [4]. They are generally nocturnal, shy
and non-aggressive. Their diet consists of other
snakes and it will therefore pursue them into human
habitation, where the prey species are hunting for
rodents. Bites generally occur when kraits are dis-
turbed by sleeping humansmoving, either naturally,
or during REM sleep [5]. A signiﬁcant number of
patients die before they reach the hospital, largely
due to the fact that the bite does not inﬂict sufﬁ-
cient pain or as a result of the bite itself or venom
action and the victims are therefore unaware that
they have been bitten.
In reported outcomes in proven common krait
bites from Northwest India, mortality has been as
high as 77% [6]. However since the availability of
assisted ventilation, mortality is considerably lower
in those patients who reach hospital in time.
The role of anticholinesterases in reversing neu-
roparalysis is controversial [5,7—12]. Kularatne
et al. from Sri Lanka reported the failure of
anticholinesterases and polyvalent antivenom in
reversing paralysis or reducing duration of ven-
tilation in 210 patients (99 with the identiﬁed
snake) bitten by common krait (B. caeruleus) [5]. In
Malayan krait (Bungarus candidus), one patient was
reported as responding to neostigmine [7]. Anti-
cholinesterase drugs, e.g. neostigmine, if proven
effective in improving response to pre-synaptic
envenomings such as krait bites, they can poten-
tially present a signiﬁcant intervention in improving
patient outcome. Available polyvalent anti-snake
venom (ASV) in India are only in lyophilized form
and takes 30—60min to be reconstituted. If anti-
cholinestrase drugs are proven to be effective they
could be deployed more rapidly and may improve
patient outcome.
The present study was undertaken to establish
the proﬁle of venomous snake bite victims admitted
in our hospital. We documented clinical features,
outcome, efﬁcacy of polyvalent antivenom and
anticholinesterase, i.e. neostigmine in reversing
neuroparalysis. As well to deﬁne optimum inten-
sive caremanagement of common krait envenoming
bite.Patients and methods
This study was carried out over a period of 18
months from late June 2007 to 31 December 2008.
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ll the consecutive patients with conﬁrmed enven-
ming admitted to the emergency ward of Nehru
ospital attached to the Postgraduate Institute of
edical Education and Research, Chandigarh, a ter-
iary care referral center in Northwest India, were
ncluded in this study.
The details of age, sex, socioeconomic status,
ime, place and site of bite, clinical assessment,
nvestigations and treatment were all recorded
n proforma developed by the National Snakebite
ommittee in 2006 at the National Snakebite Meet-
ng in Kochi (India). Patients were identiﬁed as
aving been bitten by common krait either by study-
ng the characteristics of the snake, where the
ead snake was produced, or identifying the snake
rom morphological description provided by patient
nd by showing them formalin preserved snakes.
f it was still not possible to conﬁrm the species,
linical features and circumstantial evidence were
mployed to identify the snake. The dead snakes
rought by patients/attendants were preserved in
0% formalin and identiﬁed by an experienced
erpetologist, using standard morphological keys
IDS).
Patients were assessed at the time of admis-
ion and then periodically until ﬁnal outcome.
hey were assessed for neurotoxicity, i.e. pto-
is, eye movements, pupillary size and reaction
o light, power of neck ﬂexors and limbs, respi-
atory rate, chest expansion, strength of speech,
evel of consciousness, blood pressure and local
ffects. The muscle power was graded from 0
o 5 using British Medical Research Council cri-
eria and subsequently severity of neuromuscular
eakness was graded as mild, moderate and
evere. The alteration in consciousness was cat-
gorized as normal, drowsy, semiconscious and
nconscious.
Patients with conﬁrmed krait envenoming were
iven initial resuscitation if required and then
dministered 10 vials (100ml) of polyvalent anti-
nake venom (Bharat Serum and Vaccines Ltd.),
ntravenously. In 10 patients the dose was repeated
ithin 2 h as symptoms had not improved or
ad worsened. In addition, patients were given
hree injections of neostigmine (1.5mg each) I.V.
fter administration of 0.6mg of atropine. After
ach administration of neostigmine, patients were
ssessed at 10 and 20min for any objective
mprovement in ptosis, respiratory, neck muscle
eakness, etc. Assisted mechanical ventilation
as provided when patients had saturated oxygen
elow 85% or pO2 ≥60mmHg.
The statistical analysis was undertaken using
PSS 15.0. The Ethics Committee of the Institute
ad approved the research project.
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esults
ighty-nine patients (M: 61; F: 28) were admitted
ith venomous snakebite and conﬁrmed envenoma-
ion during the study period. Seventy-three patients
ad signs and symptoms of neurotoxic bites and 16
ad haemotoxic signs and symptoms, i.e. bleed-
ng or incoagulable blood. Of 73 neurotoxic bites,
ine were identiﬁed as caused by B. caeruleus,
y identifying the dead snakes brought by patients
nd attendants, using standard morphological keys,
.e. enlarged hexagonal dorsal scales, by the her-
etologist (IDS). Sixty-three were identiﬁed to be
ommon krait from the circumstances of the bite
nd morphological features described by patients if
hey had seen the snake and from clinical features.
ne was identiﬁed to be bitten by the specta-
led cobra (Naja naja) from clinical features, i.e.
ocal pain, swelling and subsequent development
f neuroparalysis and was excluded from the ﬁnal
nalysis. The remaining patients had incoagulable
lood or systemic bleeding indicative of a viper bite
ith one identiﬁed Russell’s viper (Daboia russelii).
n 15, the species of viper could not be conﬁrmed.
ll these patients were also excluded from the ﬁnal
nalysis.
Of 72 patients, 48 weremen and 24 were women.
he mean (±SD) age of men was 30.2± 9.3 years
range 15—60 years) and of women was 29.4± 9.0
ears (range 16—65 years). All the patients were
dmitted between late June and September. All the
atients except two were from rural areas. Sixty-
wo patients were bitten at night (11 pm—5am)
hile they were sleeping. However 11 patients
ere bitten while clearing bricks, cutting grass and
alking. The mean interval from bite to hospital
dmission was 4.8 h (range 0.5—10 h).
Abdominal pain was the ﬁrst symptom to man-
fest within a few minutes to hours in more than
alf of the patients. Other common clinical fea-
ures were weakness of limbs and inability to stand,
w
w
d
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Table 1 Symptoms and signs in 72 victims of B. caeruleus
Symptoms and signs Men (48)
Abdominal pain 38
Dyspnoea 10
Giddiness 2
Nausea 2
Vomiting 1
Altered sensorium 3
Ptosis 47
Weakness of neck ﬂexors 36
Respiratory failure 7
Hypertension 6
Local reaction 0
Mean interval between bite and admission in hospital = 4.5 h.85
rooping of eyelids, difﬁculty in breathing and
ltered sensorium (Table 1). Less commonly was par
esthesia at the site of bite. In all the patients the
ang marks were indistinct and local reaction was
inimal to faint.
None of the 72 patients administered three
njections of neostigmine at 30min interval pre-
eded by one injection of 0.6mg of atropine,
howed any improvement or reversal in neuromus-
ular paralysis following administration. Sixty-two
atients received 10 vials (1 vial = 10ml) of
yophilized polyvalent antivenom. Ten patients
eceived another 10 vials of polyvalent antivenom
ithin the next 2 h, as there was a deterioration
r lack of improvement in the victim’s condition.
owever despite antivenom, all victims developed
espiratory paralysis and required assisted mechan-
cal ventilation with mean duration of 39.5 h (range
h—20 days). Four patients developed respira-
ory failure before arrival at the hospital, and
ere intubated and supported with a resuscita-
ion bag. Twenty-two patients required assisted
entilation (SIMV mode) for less than 24 h, 40 for
etween 24 and 72 h, 10 for more than 72 h, and
patient required assisted ventilation for 20 days.
wo patients did not survive, the cause of death
eing hypoxic brain damage occurring before reach-
ng the hospital.
iscussion
n Northwestern India, neuroparalytic common
rait bite is an important emergency as majority
f the population, approximately 70%, live in rural
reas and are engaged in farming. Unlike the study
y Kularatne et al. from Sri Lanka where men and
omen were equally affected, in our study men
ere bitten nearly twice more than women. This
ifference is probably due to the fact that men
arry out the majority of agricultural activities in
bite on admission.
Women (24) Total %
14 52 72.2
8 18 25.0
0 2 2.9
0 2 2.9
1 2 2.9
1 4 5.8
23 70 97.1
14 50 70.0
3 10 10.4
3 9 10.2
0 0 0
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this part of India. Majority of the males involved are
menwhomigrate from the poorer eastern regions of
India and work as agricultural laborers not sharing
accommodation with wives or children.
Sixty-two bites occurred while the victims were
sleeping and 10 occured during activities like grass
cutting, clearing bricks, and walking, similar to
other reported studies [1,2,5]. The mean time
interval between bite and admission to hospital
(4.5 h) was shorter in our study than that reported
by others [5]. This is probably due to high awareness
among the public in the region about the hazards
of snakebite and the need for rapid hospitalization
and existence of better transport facilities.
Studies of deﬁnitive krait bites have docu-
mented severe respiratory paralysis and the need
for prolonged ventilatory support [3,5—8]. Electro-
physiological studies have shown that envenoming
bites by kraits are associated with a reduction
in the compound muscle action potential and a
decremental response to repetitive nerve stimu-
lation [13]. Animal studies have shown that the
venom of kraits contains three major types of neu-
rotoxins of which -bungarotoxin causes failure
of neuromuscular transmission by binding to post-
synaptic neuronal acetylcholine receptors (nAChR)
at the neuromuscular junction [14]. The second
neurotoxin is -bungarotoxin which is exclusively
found in the venom of kraits. It is structurally simi-
lar to -bungarotoxin and binds to neuronal AchR
post-synaptically [15]. The third pre-synaptically
active -bungarotoxin constitutes >20% of protein
content of the krait venom and causes the fail-
ure of neuromuscular transmission for long periods
by depleting synaptic vesicles at nerve terminals
[16—18]. It further leads to structural damage of
motor nerve terminal and the destruction is com-
plete by 12—24 h [16—20]. It has been postulated
that -bungarotoxin alone or in combination with
-bungarotoxin is predominantly responsible for
severe paralysis. Recovery therefore depends on
the regeneration of synaptic vesicles, which takes a
signiﬁcant time leading to requirement of mechan-
ical ventilation considerably in excess of that in
post-synaptic envenomings [17].
Timely administration of appropriate antivenom
is the mainstay of treatment for snakebite, as
there exists a good correlation between devel-
opment of complications and administration of
antivenom. Although antivenom was administered
early in our study, it did not prevent the devel-
opment of neuroparalysis. This is probably due to
rapid binding of -bungarotoxin to its binding site
on nerve terminals with process being complete
as early as within 5min [21]. Despite the fact
that antivenom has no effect on bound venomous
CA. Anil et al.
ntigen at the neuromuscular junction, it undoubt-
dly neutralizes free ﬂowing venom. Theakston
t al. [22] have clearly shown the clearance of
enom antigenemia following intravenous polyva-
ent antivenom, leading to reduced severity. Even
hough all the patients developed respiratory paral-
sis and required assisted mechanical ventilation
espite antivenom administration, the mean dura-
ion of assisted ventilation was much shorter (mean
9.5 h) than other studies. It is likely that the
ntivenom neutralized free ﬂowing venom leading
o its rapid clearance and thereby less severe neu-
oparalysis and thus shorter duration of assisted
echanical ventilation. The mortality in our study
as very low (2/72) as compared to a previous study
rom India [6] where mortality was 77%. The reason
or low mortality in our study is the better avail-
bility of ventilatory support and intensive care
acilities.
In previous evaluations adequacy of response to
nticholinesterase in neurotoxic envenoming bites
ave been raised. Beneﬁcial effects have been
emonstrated in individual patients, but the results
rom series have been inconsistent [5,7—12]. This
s probably because of inclusion of krait bites in
hese series [12]. The krait -bungarotoxin is com-
letely resistant to them [23]. In our study, all the
atients were given neostigmine. Three doses were
dministered in this study, given in accordance
ith existing practice at the hospital. The Indian
ational Snakebite Protocol recommends a single
ose of intramuscular neostigmine, with atropine,
n line with the diagnostic test for myasthenia
ravis [24]. Although this study employed a higher
ose regimen it did not improve the neuroparalytic
ymptoms. Neostigmine appears to have no use-
ul role in conﬁrmed pre-synaptic envenoming and
n patients where the identiﬁcation of the biting
pecies is conﬁrmed, neostigmine can be withheld.
This study was carried out at a tertiary hospital
quipped with mechanical ventilation equipment.
uch hospitals are few in developing countries and
ost frequently victims report to basic medical
acilities with no mechanical ventilatory support.
t is essential therefore to ensure guidelines for
nakebite treatment to include measures to provide
etter airway support in basic settings, particularly
here long journeys to better-equipped hospitals
ccur [24,25].onﬂict of interest
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